Dr. Iyabo Tinubu-Karch

CEO, Sidra Medicine
Ex-Officio Member of the Board of Governors

Dr. Iyabo Tinubu-Karch is the Chief Executive Officer and Board Member Ex-Officio of Sidra Medicine, a women’s and children’s hospital in the State of Qatar. She joined the healthcare organization in November 2022.

Prior to her appointment as the CEO of Sidra Medicine, Dr. Tinubu-Karch was actively involved with the management team of the healthcare organization, in her previous capacity as a non-executive board member since 2019 as well as in an advisory role with the management committee.

Since joining Sidra Medicine as the CEO, Dr. Tinubu-Karch’s leadership has witnessed the strengthening of the organization’s precision medicine strategy to advance healthcare in Qatar and around the world. She has overseen the expansion and launch of several pioneering clinical and research programs and initiatives for women and children and has forged partnerships with key local and global institutes.

In 2023, she led a hospital-wide effort resulting in its reaccreditation by Joint Commission International; oversaw the opening of the GMP facility and several groundbreaking clinical research projects related to precision medicine, diabetes and monogenic obesity. She signed an MoU with Al Koot Insurance, GlobeMed and with Nazarbayev University in Kazakhstan to facilitate clinical, research and educational collaboration.

In 2024, Dr. Tinubu-Karch led the expansion of Sidra Medicine’s genome sequencing and gene therapy programs for children with Spinal Muscular Atrophy and Duchene Muscular Dystrophy. She also oversaw the launch of the healthcare organization’s clinical trials program and the successful implementation of clinical grade Whole Genome Sequencing (WGS), as an advanced diagnostic-grade genetic test for patients. 2024 also witnessed the signing of agreements with key healthcare organizations including Children’s Hospital of Philadelphia (CHOP) USA, Children’s National USA and onboarding new insurance partners, MSH International.

In 2025, Dr. Tinubu-Karch led the establishment of a Gene Therapy center and the opening of the new pediatric Hematopoietic Stem Cell Transplant (HSCT) ward. Key partnerships under her leadership in 2025 include agreements with Rasmal Ventures; LGA Group; Izmir Biomedicine and Genome Center in Turkey; Children’s Hospital LA USA; Great Ormond Street Hospital (GOSH) UK and Vitafluence.ai to advance AI driven healthcare innovation.

Dr. Tinubu-Karch has been consecutively listed in 2024 and 2025, in Forbes Middle East’s 100 Most Powerful Businesswomen in the Middle East.

Dr. Tinubu-Karch has extensive clinical experience in general internal medicine, hospital and geriatric medicine. She is certified in health information technology and has led several international based programs about the application of technology in clinical medicine. She also holds numerous high-profile board appointments and memberships in leading healthcare colleges and societies in the United States of America.

Prior to joining Sidra Medicine, Dr. Tinubu-Karch was the clinical instructor at the University of Washington, School of Public Health.  Her previous experience as a practicing physician in the USA includes the Swedish Medical Center; University of Washington; the Department of Veterans Affairs in Seattle and VA Health Care Systems.

Dr. Tinubu Karch is also the founder and CEO of 6M Geriatrics and Hospital Medicine. Her international roles include serving as a consultant physician in health systems improvement at Lagos State University Teaching Hospital in Nigeria.

Dr. Tinubu-Karch received her medical degree from St. Georges University Medical School. She has a master’s degree in health administration and conducted her fellowship training in critical care from the University of Washington. She has a fellowship in geriatric medicine from the Swedish Medical Center and completed her residency in internal medicine from Lennox Hill Hospital.

Dr. Tinubu-Karch is a past recipient of the Washington State health information technology grant and previously served on the Washington State Medical Association Health Informatics Advisory and Accreditation Committees.